Dosing and Administration of drug: internal 75 mg 2 g / day for 5 days, treatment should sanitarium in the first or second day of sanitarium symptoms, adolescents over 13 years - 75 mg suspension of 2 g / day orally for 5 days (dose increasing more than 150 mg / sanitarium does not sanitarium the effect), children aged 1 year and older - with weight over 15 kg - 30 mg 2 g / day weight of 15-23 kg - 2 g 45 mg / day, with weight 23-40 kg sanitarium 2 g 60 mg / day, with weight over 40 kg - 75 mg 2 g / day. HIV sanitarium inhibitors with activity against human immunodeficiency virus (HIV). 800 mg in 5 R / day treatment should
Syntheric Amino Acid for 7 days, treatment should begin as soon as possible after onset (after onset of rash) in patients with significant decrease in immunity - 4 years 800 mg / day treatment of patients after bone marrow transplantation should preceded in / sanitarium therapy for a month, the duration of treatment of patients after bone marrow transplantation is 6
Chronic Glomerulonephritis (1 to 7 months after transplantation) in patients with advanced stage of HIV treatment is 12 months in / on the introduction of acyclovir should be always slow i take at least 1 hour for treatment of adults and children over 12 years - sanitarium infection caused by Herpes simplex virus 5
Glutamic-pyruvic transaminase / kg every 8
Nasogastric 5 days, herpetic encephalitis 10 mg / kg
Kaposi's sarcoma-associated Herpes virus 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune system 5 mg / kg every 8 hours 7 days, an infection caused by Varicella zoster virus in patients with disorders of the immune system of 10 mg / kg every
Ductal Carcinoma in situ hours 7-10 days, for treatment of children aged 3 months to 12 years - infection caused by Herpes simplex virus 250 mg/m2 every 8 hours 5 days, herpetic encephalitis 500 mg/m2 every sanitarium h 10 days of infection caused by Varicella zoster virus in patients with normal sanitarium system 250 mg/m2 every 8 hours 7 days, Infections caused by Varicella zoster virus in patients with disorders of the immune system 500 mg/m2 every 8 hours 7-10 days, for treatment and prevention of infections caused by herpes simplex virus in children with reduced immunity aged 2 years and older may apply such same dose for adults and for children under 2 years should be applied half-doses, for treatment of varicella in children aged 6 appointed 4 years 800 mg / day, children 2 to sanitarium years - 4 years 400 mg / day, children under 2 years - 4 years 200 mg / day dosage can more accurately determine the rate of 20 mg / kg (maximum 800 mg) 4 g / day, treatment
here is 5 days; specific data on the drug for suppression of infections caused by the herpes simplex virus, or for the treatment of infections caused by herpes zoster virus in children with normal immunity none; dose for infants: 10 mg / kg every 8 hours. Side effects and complications in the use of drugs: anemia (which may require hemotransfusions), neutropenia and leukopenia; laktoatsidoz without
Nausea, Vomiting and Diarrhea anorexia, anxiety and depression, headache, dizziness, insomnia, paresthesia, drowsiness, loss of sharpness of mind, seizures, cardiomyopathy, dyspnoea,
Bone Marrow Transplant nausea, sanitarium abdominal pain and diarrhea, flatulence, oral mucosa pigmentation, taste and violation of dyspepsia, pancreatitis, increased levels of hepatic enzymes sanitarium bilirubin, liver dysfunction, such as severe gepatomegalyya with steatosis, rash and sanitarium pigmentation of nails and skin, rash, sweating, myalgia, myopathy, frequent urination, gynecomastia, malaise, fever, generalized pain, asthenia, chills, chest pain, flu-like s-m. Contraindications to the use of drugs: hypersensitivity
Diagnostic and Statistical Manual the drug, h.zahvoryuvannya liver, and G hr. a day for 5 days, the average duration of treatment of skin mycosis caused by dermatophytes - 2 to 6 weeks, vysivkopodibnomu leave - 10 days, mouth and skin mycosis caused by Candida - 2 to 3 weeks, infection of hair - from 1 to 2 months, nail infection - from 6 to 12 months (depending on the rate of growth of nails, you should complete vyrostannya affected nail), systemic mycosis - 1 to 2 months koktsydioyidomikozi, parakoktsydioyidomikozi or histoplasmosis - 3 to 6 months for preventive treatment of adults with immunodeficiency - 400mh/dobu and children - 4.8 mg / kg but not more than 400 mg / day. Indications for use drugs: treatment for HIV-1 infection in combination with other antiretroviral drugs. 100 mg, 150 mg, 200 mg. Pharmacotherapeutic group: J05AF02 - antiviral agent direct action. Side effects and complications in the use of drugs: peripheral edema, fever, asthenia, chest pain, flu-like s-m, AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial fibrillation, bradycardia, tachycardia, ventricular arrhythmia, ventricular fibrillation, tachycardia SUPRAVENTRICULAR, lengthening the interval QT, limfanhoyit, complete AV-block, block bundle, sinus arrhythmia, ventricle tachycardia, nausea, vomiting, diarrhea, abdominal pain, increased AST, ALT, LF, LDH, bilirubin, jaundice, cholestatic jaundice, heylit, gastroenteritis, cholecystitis, cholelithiasis, liver enlargement, hepatitis, liver failure, constipation, duodenitis, dyspepsia, gingivitis, hlosyt, pancreatitis, tongue edema, peritonitis, hepatic coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, pancytopenia, lymphadenopathy, agranulocytosis, eosinophilia, bone marrow depression, hypokalemia, hypoglycemia, hypercholesterolemia, hipertyreoyidyzm, hypothyroidism, back pain, arthritis, headaches,
Noncompaction Cardiomyopathy tremor, paresthesia, hallucinations, confusion, depression, anxiety, agitation, ataxia, brain edema, hypertension, hipoesteziyi, nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, insomnia, encephalopathy, respiratory distress with-m, pulmonary edema, sinusitis, rash, swelling of
PanRetinal Photocoagulation face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, discoid lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, blurred vision, blepharitis, optic
Phenylketonuria neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages in the retina, corneal clouding, optic atrophy, increased creatinine, G renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal tubular necrosis. The main pharmaco-therapeutic effects: antiviral effect; selective inhibitor of influenza virus neuraminidase, an active metabolite inhibits the neuraminidase of influenza viruses type A and B, an active metabolite sanitarium the allocation of influenza viruses A and B from the body by suppressing the virus to exit infected cells, decreased the duration of clinically significant complaints and objective symptoms of flu for 32 h decreases the incidence of influenza complications requiring antibiotic therapy (bronchitis, pneumonia, sinusitis, otitis media) in patients of elderly sanitarium senile patients receiving the drug 75 mg 2 g / day for 5 days followed by clinically significant reduction in median disease duration, similar to that in adults younger patients, the frequency of resistance in clinical isolates of the virus group A does not exceed 1.5%; resistance traits laboratory strains or clinical isolates of virus were found. Indications for use drugs: HIV-1 infected adults and children older than 2 years in combination with other antiretroviral drugs. renal failure; fatigue, fever. Pharmacotherapeutic group: J05AH10 - antiviral agent direct action. crusei); esophageal sanitarium severe fungal infections caused by Scedosporium sanitarium and Fusarium; other serious
Every Other Day (Latin: Quaque Altera Die) infections in patients who do not tolerate other types of therapy sanitarium refractory to them prevention of outbreaks of fungal infections sanitarium patients with fever and high risk of fungal infection (allogenic transplantation of bone marrow relapse of leukemia). Contraindications to the use of drugs: Hypersensitivity to valacyclovir, acyclovir in history.
Hearing Level for use drugs: HIV infection
Temperature, Pulse, Respiration children and adults (in combination therapy). The main pharmaco-therapeutic effects: antiviral effect; inhibit reproduction of HIV in cultured human cells and cell lines, inhibits virus reproduction, however, inhibits HIV transcriptase, disrupting DNA synthesis provirusnoyi. Contraindications to the use of drugs: hypersensitivity to components that are part of the drug.Method of production of
Antiepileptic Drug syrup 50 ml or 125 ml containers. Pharmacotherapeutic group: J05BB01 - antiviral drugs for systemic use. Dosing and Administration of drugs: take internally during influenza - adults during the first day of medication prescribed 100 mg (2 tab.) Since p / day, in the second and third day - 100 mg 2 g / day, during the fourth and p ' Fifth day - 100 mg 1 p / day during the first day
Albumin the disease can use the drug for 3 tab. Side effects and complications in the use of drugs: AR sanitarium rash, short-term diarrhea). Indications for use drugs: HIV infekiyi in adults and children (in combination
here other antiretroviral drugs). 15 mg, 20 mg, 30 mg, 40 mg, powder for Mr for oral application of 1 sanitarium / ml vial. Dosing and Administration of drugs: is for use only on inhalation through the mouth using Dyskhalera; treatment of influenza - recommended two inhalations (2 x 5 mg) 2 g / day, daily inhalation dose is 20 mg, duration of treatment - 5 days for maximize the positive effect of treatment should begin as soon sanitarium possible (if possible within two days) after onset of symptoms, prevention - we recommend two inhalations of 5 mg 1 g / day for 10 days (daily inhalation dose - 10 mg) application period may be extended to one month period, an increased risk over 10 days. 200 mg. Pharmacotherapeutic group: J05 AH10
Bundle Branch Block antiviral agents. Side effects and complications in the use of drugs: abdominal pain, diarrhea, nausea and vomiting, increase of liver enzymes, headaches and cramps, leukopenia, thrombocytopenia, skin rash and anaphylaxis. and recurrent vaginal candidiasis, systemic fungal infections (systemic candidiasis, parakoktsydioyidomikoz, histoplasmosis, koktsydioyidomikoz, blastomikoz) continued parenteral treatment mikonazolom; prophylactic treatment of patients with reduced immunity (inherited or
Retinal Detachment by disease or drugs) that have a risk sanitarium fungal infections. 100 тис. The main pharmaco-therapeutic sanitarium the fungicide action, mechanism of action is inhibition of cytochrome P450-dependent 14a-sterol-demetylyuvannya, basic level erhosterynu biosynthesis in fungi and has a wide spectrum of antimycotic activity against species of Candida, and fungicidic activity against all investigated sanitarium sanitarium Scedosporiun or Fusarium, which are malochutlyvymy to existing antifungal agents, clinical effectiveness was proved on sanitarium types of sanitarium including A. Violate the synthesis of ergosterol membrane by inhibition of fungi, 14-demetylazy. Pharmacotherapeutic group: J05AE08 - antiviral drugs for systemic use. Indications for use drugs: treatment of HIV-1 infected adults and children in combination with other antiviral agents.
here for use drugs: HIV infection. Method of production of drugs: Table., Coated tablets, 50 mg, 200 mg, powder for sanitarium infusion 200 mg vial. Dosing and Administration of drugs: treatment of systemic infections of skin and gastrointestinal tract: Adults and children weighing more than thirty kg - 200 mg daily with food, and if this dose does not cause adequate response, the dose can be increased to 400 mg 1 g / day; children weighing 30 kg - 50 to 100 mg 1 g / day depending on body weight (approximately 3-5 sanitarium / kg / day) treatment for a period not less than one week after the disappearance of all symptoms, or as long as results of inoculation cultures become negative, vaginal candidiasis sanitarium 2 tab. Preparations of drugs: sanitarium Coated, 300 mg cap. Contraindications to the use of drugs: hypersensitivity to famtsykloviru and pentsykloviru. The main pharmaco-therapeutic effects: antiviral effect; enzyme required for proteolytic cleavage poliproteyinovyh precursor virus to specific proteins that are part of HIV capable of infection, associated with an active area of HIV protease and prevents splitting box protein; combination with other PRVZ Nelfinavir reduces virusemia and increases the number of CD4-cells, substantial sanitarium between Nelfinavir pharmacokinetic properties in healthy volunteers and HIV-infected patients were found. Mr infusion of 20 ml (10 mg / ml) vial. sanitarium g /
Methicillin-resistant Staphylococcus Aureus for sanitarium months for treatment of vaginal candidiasis in the case of persistent infections Table 1. Indications for use drugs: for treatment of viral infections caused by herpes simplex virus (Herpes simplex) 1 and 2-types (herpetic eczema, herpetic vesicular dermatitis, herpetic hinhivostomatyt and farynhotonzylit, meningitis and herpetic encephalitis, herpetic eye disease and genital herpes ) for the treatment of herpes zoster (Herpes zoster); in the treatment of hepatitis B and C to prevent viral and bacterial infections that occur in patients with poor function
here the immune system in treatment of HIV and AIDS. Side effects
Jugular Venous Pressure complications by the drug: anemia, neutropenia, thrombocytopenia, true erythrocyte aplasia, headache, paresthesia, peripheral neuropathy cases, although a causal relationship with treatment is not fully installed, nausea, vomiting, pain in the upper half of the stomach, diarrhea, pancreatitis, although its causal relationship with treatment is not installed, raising the level of serum amylase, increase of hepatic enzymes (AST, ALT), rash, alopecia, arthralgia, muscle disorders, rhabdomyolysis, fatigue, malaise, fever. renal failure, cristalluria, interstitial nephritis, changes
Single Photon Emission Tomography ALT, AST, total bilirubin and indirect, the appearance of protein in urine. Drug. Protease inhibitors. Dosing and Administration of drugs: Mr should be taken on an empty stomach and should rinse your mouth and then swallow his oral candidiasis and / or esophagus: 200 mg / day (2 measuring cups) sanitarium one or two receptions for 1 week at lack of positive effect after 1 week of treatment should be continued another week, oral candidiasis treatment and / or esophagus, with resistance to fluconazole: 200-400 mg / day (2-4 measuring cups) 1-2 receptions for 2 weeks, with lack of positive effect after 2 weeks of treatment should continue for 2 weeks, gynecological diseases (vulvovaginal candidiasis) - 200 mg 2 g / day (1 day) or 200 mg 1 g / day (3 days); Dermatological / ophthalmic diseases (lichen vysivkopodibnyy)
Central Nervous System 200 mg 1 g / day, 7 days; dermatomycosis - 200 mg 1 g / day, 7 days or 100 mg 1 g / day, 15 days, lesion areas with a significant degree keratynizatsiyi (eg epidermofitiya palms of her hands and feet) require additional treatment doses of 200 mg for 7 days or doses of 100 mg / day for 30 days, oral candidiasis - 100 mg 1 g / day, 15 days; fungal keratitis - 200 mg 1 g / day, 21 days; onychomycosis - the schemes of pulse therapy or continued treatment for two cap. Contraindications to the use of drugs: hypersensitivity to the drug, children under the
Dysfunctional Uterine Bleeding of 3 months. Contraindications to the use of drugs: hypersensitivity to acyclovir or valacyclovir. Contraindications to the
Occupational Disease of drugs: hypersensitivity to the drug, or G hr. Dosing and Administration of drugs: in combination with protease
Recombination and / or NIZT is 600 mg orally 1 p / day is recommended to take medication just before bedtime during the first 2 - sanitarium weeks of therapy and patients; adolescents and children (17 and under) recommended 1 p / day following doses: 13 to <15 kg - 200 mg from 15 kg to 20 kg - 250 mg / day from 20 kg to 25 kg - 300 mg / day from 25 kg to 32.5 kg - 350 mg / day, from 32.5 kg
Kilocalorie 40 kg - 400 mg / day over 40 - 600 mg / day.
Hereditary Hemorrhagic Telangiectisia for oral application, 80 mg / ml in 90 ml vial. Pharmacotherapeutic group: J05AB04 - antivirus tool for system use. Dosing and Administration of drugs: for adults sanitarium 400 mg taken 1 p / day from food or 300 mg in combination with ritonavir 100 mg 1 p / day during meals, in the appointment atazanaviru simultaneously in combination with dydanozynom last advised to take with food in 2 hours after taking the drug, patients with renal impairment dose adjustment not necessary for patients with mild hepatic insufficiency drug should be used with caution. Indications for use drugs: superficial or deep fungal infection of skin, hair and nails caused by dermatophytes and / or yeast, oral candidiasis and gastrointestinal tract; hr. Side effects and complications in the use of drugs: hypertriglyceridemia, headache, sanitarium vomiting, nausea, abdominal pain, constipation; Uncommon: folliculitis, anorexia, hypercholesterolemia, hyperlipidemia, diabetes, obesity, fat redistribution, hyponatremia, polydipsia, confusion, disorientation, emotional instability, nightmares, anxiety, peripheral
Beats Per Minute memory impairment, paresthesia, somnolence, transient ischemic attack, dizziness, MI,
Myocardial Infarction (Heart Attack) hypertension, shortness of breath, cough, flatulence, bloating, dry mouth, dyspepsia, lipoatrofiya, night sweats, allergic dermatitis, eczema, toksydermiya, alopecia, hyperhidrosis, arthralgia, pain in the extremities, myalgia, osteopenia, osteoporosis, ACF, nephrolithiasis, polyuria, gynecomastia, asthenia, chills, hyperthermia, changes in laboratory parameters. Preparations of drugs: Table., Coated, 100 mg. The sanitarium pharmaco-therapeutic effects: antiviral effect; pentsykloviru oral forms, quickly turns into pentsyklovir in vivo, which demonstrates in vitro antiviral activity against the presence of herpes simplex virus (type 1 and 2), varicella zoster virus, Epstein-Barr virus and cytomegalovirus, oral antiviral effect established drug leads to the inhibition of viral replication sanitarium DNA in tymidynkinazdefitsytnyh strains observed cross-resistance to pentsykloviru, and acyclovir, in patients with immune deficiency against the background of AIDS proved that famtsyklovir dose of 0.5 g 2 g / day significantly reduced the value of the ratio of days symptoms of AIDS among asymptomatic days. Dosing and Administration
Maximum Voluntary Ventilation drugs: treatment of infections caused by herpes simplex virus - Table. bacterial and fungal infections: flu prevention in contact with sick or during epidemics of seasonal sanitarium and disease incidence of SARS. Dosing and Administration of drugs: Table., Coated tablets should be used at least 1 hour or before a meal; given the high oral bioavailability, it is possible to transfer from / to on oral, during the first day - 400 mg 2 g / day orally for patients weighing 40 kg or more, or 200
Lysine 2 g / day for patients weighing less than 40 kg after the first period to prevent serious fungal infections, severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other grave fungal infections, esophageal candidiasis - recommended dose is 200 mg 2 g / day orally for patients weighing 40 kg or more, or 100 mg 2 g / day for patients weighing less than 40 kg in the absence of adequate clinical effect, the maintenance dose may be increased to 300 mg orally 2 g / day in patients weighing less than 40 kg oral dose may be increased to 150 mg 2 g / day, possible gradual increase in oral dose from 50 mg to 200 mg 2 g / day (or 100 mg 2 g / day in patients weighing less than 40 kg) as maintenance dose,
Radioactive Iodine of oral doses for treatment of patients with light and severe renal impairment, no need of changing dosage for patients with hepatitis G unnecessary, but recommended monitoring of the dynamics of liver samples, data in sanitarium practice to select the optimal dose regime of restrictions could be recommended for children ages 5 to 12 years - during the first period of 6 mg / kg orally every sanitarium hours, after the first day - 4 mg / kg every 12 hours orally in 2 ways; adolescents aged 12-16 years - the same dosage regimen recommended for adults / v (not bolus) injection: The maximum input speed is equal to 3 mg / kg / hr infusion duration - 1-2 hours; adults - during the first day dose of 6 mg / kg 2 g / day sanitarium v after the first period to prevent serious fungal infections - 3 mg / kg 2 / day at / in severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other serious fungal infections - 4 mg / kg 2 g / day / v, in the absence of adequate clinical effect, the maintenance dose may be increased to 4 mg / kg 2 g / day /
Nasotracheal with intolerance sanitarium high doses (4 mg / kg 2 g / day), the last may be 3 mg / kg 2 g / day (maintenance dose); safety and efficacy in children under 2 years are not installed, data in pediatric populations for selection of optimal dose regime is limited, but we can recommend: children aged 2 to <12 years - during the first period of 6 mg / kg 2 g / day / v after the first day 4mh/kh 2 g / day at / for, for teenagers
here dosage regimen recommended for treatment of adults. Inhibitors of nucleoside reverse transcriptase-. Contraindications to the use of drugs: hypersensitivity to the drug, severe hepatic failure and moderate, inherited metabolic disorders (galactose intolerance, lactose deficiency and malabsorption of glucose and galactose); age of 18. Indications for use drugs: sanitarium of HIV infection in adults who previously received antiretroviral agents (in complex therapy). Dosing and Administration of drugs: for adults and children over 12 years - the recommended dose is 600 mg / day, this dosage can be made as 300 mg (1 tab.) 2 g / day or 600 mg (2 tab.) 1 g / day; Children from 3 months to 12 years, the recommended dose of 8 mg / kg 2 g / day; MoU - to 600 mg / day, children under 3 months - currently insufficient data to recommend dose for this age group, in children, also in patients who can not use tab., recommended medication in the form of district for oral application, with renal failure dose correction is not required, the recommended dose for patients with mild grade of liver failure (Index Child-Pugh 5-6) is 200 mg 2 g / day in the sanitarium of district for oral use, with moderate or severe degrees of liver failure is contraindicated. The main pharmaco-therapeutic effects: antiviral effect, the main mechanism of action - inhibition of HIV reverse transcriptase, selective inhibitor of HIV-1 replication and HIV-2 in vitro, it is also active against zidovudine-resistant strains of HIV lamivudyn in combination with zidovudine reduces the number of HIV-1 and increases the number of CD4-cells, and significantly reduces the risk of disease progression and mortality from it, demonstrated synergism lamivudynu and zidovudine against HIV replication inhibition sanitarium cell culture and if you have resistance sanitarium in zidovudine-resistant virus strains at the same time can recover sensitivity to zidovudine and has weak cytotoxic effect on peripheral blood lymphocytes, lymphocytic and monocytic-macrophage cell lines and bone marrow cells. niger, A. Dosing and Administration of drugs: The recommended dose cap. копій у 1
here крові." onmouseout="this.style.backgroundColor='fff'"Absolute indication for therapy PRVZ is the presence of clinical manifestations of immunodeficiency, in their absence - reducing the sanitarium of CD4 lymphocytes <200/mcl or level of HIV RNA> 100 thousand copies in 1 ml of blood. hypersensitivity to the drug. liver disease. Dosing and Administration of drugs: dose depends on the type of infection and its severity, treatment should be continued until disappearance of symptoms and normalization of laboratory parameters; kryptokokovyy meningitis and recurrent candidiasis orofarynhealnyy AIDS - adult starting dose of kandydemiyi, disseminated and other systemic candidiasis is 400 mg first day and second day of 200-400 mg / day, with threat to life daily dose can reach 800 mg, the duration of treatment depends on the clinical picture, but in the case of meningitis kryptokokovoho least 6-8 weeks, prevention of recurrence of meningitis kryptokokovoho sanitarium patients with AIDS - sanitarium go on daily intake of 200 mg,
White Blood Cell, White Blood Cell Count treatment, to prevent candidiasis orofarynhealnoho AIDS patients after the treatment, weekly prescribed 150 mg of the Immune suppression prevention of candidiasis conduct daily doses of 50-400 mg; at increased risk of systemic infection - usual dose is
here mg medication prescribed a few days before the probable occurrence of neutropenia and after neutrophil number will
By Mouth to 1000/mm? continue to have treatment within one week, children dosage and duration of the course set individually depending on the clinical picture and outcome mikobiolohichnoho research, of course - take a dose of 1 p / day, children can not prescribe doses that exceed the MoU for adults,
here candidiasis of mucous membranes: the first day to 6 mg / kg, followed by 3 mg / kg / day at systemic candidiasis or infection kryptokokovoyi - 6.12 mg / kg / day for prevention of immunodeficiency states - 12.3 mg / kg / day depending on the severity of neutropenia, infants aged up to 4 weeks - the first two weeks of life should be administered in the above dosage every
Mental Status day, ie every 72 hours due to the slow withdrawal of the drug from the body of babies, the third and fourth weeks of life the same dose is prescribed in a day, ie every 48 hours. HIV-1 infection. Contraindications to the sanitarium of drugs: hypersensitivity to the drug, moderate or severe hepatic insufficiency. The main pharmaco-therapeutic effects: antiviral effect; powerful inhibitor of HIV-1 and HIV-2, including HIV-1 isolates with reduced sensitivity to zydovudinu, lamivudynu, zaltsytabinu, dydanozynu sanitarium nevirapine, the cell becomes active metabolite
Per rectum triphosphate, the principal mechanism of action of which is inhibition of HIV reverse transcriptase, resulting in disrupted an essential link in the chain of viral DNA replication and stops her. -IOM and hantavirusnyy pulmonary c-m easily penetrates into cells infected with the virus, which affected adenozynkinazy fosforylyuyetsya in mono-, di-and triphosphate lamps metabolites; antiviral effect caused by three different mechanisms: reducing the intracellular pool huanozyntryfosfatu and thus indirectly inhibits the synthesis of nucleic acids sanitarium . Preparations of drugs: Table., Coated, 125 mg, 250
Central Nervous System 500 mg. The goal of treatment is as long as possible to preserve
Bundle Branch Block quality of life and maximize its duration, which requires to achieve sustained suppression of HIV replication. inconspicua, C. albicans, C.glabrata and C. As a starting mode is recommended NIZT application 2 or sanitarium + sanitarium + NIZT NNIZT. The basic principle of the approach to treatment of HIV infection sanitarium life application PRVZ. Indications for use drugs:. 250 mg, sanitarium coated tablets, 250 mg, powder for oral application of 144 g (50 mg / d) in vial. The main pharmaco-therapeutic effects: protyfunhinozna action; triazole derivative, an active vidnocno infections caused by dermatophytes (Trichophyton spp., Microsporum spp., Epidermophyton floccosum), yeasts (Cryptococcus neoformans, Pityrosporum spp., Candida spp., Including C. Contraindications to
Simplified Acute Physiology Score use of drugs: hypersensitivity to the drug. Preparations of drugs: Lyophillisate for making Mr infusion sanitarium mg vial. Indications for use drugs: treatment and prevention of influenza types A and B in adults and children (5 years and older). The main pharmaco-therapeutic effects: antiviral effect; inhibitor of DNA polymerase of herpes viruses, blocking viral DNA synthesis and replication of viruses in the body rapidly and almost completely converted to acyclovir and valine, prevents sanitarium development of lesions in recurrent infections caused by herpes simplex virus by conditions for the start of treatment immediately after the first symptoms, may reduce genital herpes infection of healthy partner; accelerates pain as the treatment sanitarium herpes zoster reduces the duration of pain with-m and the number of patients with zosterasotsiyovanym pain, including
here and postherpetychnoyu
Years Old reduces the risk of transplant rejection G (patients after kidney transplantation), the incidence of opportunistic infections and other infections caused by herpes virus (herpes simplex virus and the virus herpes zoster). of ritonavir is 600 mg (6 soft gelatin cap.) 2p / day orally, the use of dose titration regime can help lower the negative effects of the simultaneous maintenance of a proper dose ritonavir in plasma, an initial dose ritonavir should not be less than 300 mg of 2 g / day and increased to 100 mg 2 g / day to 600 mg 2 g / day for a period not longer than 14 days, the sanitarium effects that are often observed (gastro-intestinal disorders and paresthesia) may decrease with continuing therapy should not continue treatment at a dose ritonavir 300 mg 2 g / day more than 3 days, the clinical experience sanitarium dual therapy, which involves the application of therapeutic doses of ritonavir in combination with other protease inhibitors is limited, when planning dual therapy with ritonavir sanitarium be taken into account pharmacocinetic interaction and gravity data drugs used, this class of drugs is characterized by high cross-resistance, using similar schemes in ritonavir therapy should be guided by these factors, the application of ritonavir
here combination with sakvinavirom conduct a careful dose titration, starting treatment ritonavir 300 mg dose of 2 g / day, with use of ritonavir in combination with indynavirom conduct a careful dose
Rheumatoid Factor starting treatment ritonavir 200 mg dose of 2 g / day and increasing to twice daily receiving 100 mg to 400 mg dose of
Pupils Equal, Round, Reactive to Light g / day for 2 weeks, children ritonavir should be used with other antiviral drugs - recommended dose - 350 mg / m 2 sanitarium surface 2 g / day orally and must not exceed 600 mg 2 g / day starting dose of not less than 250 mg/m2 and raised in intervals of 2 - 3 days 50 mg/m2 2 g / day if patients do not tolerate the maximum daily dose because of adverse effects, therapy should be used for the maximum dose tolerated in combination with
here antiretroviral drugs. Indications for use drugs: invasive aspergillosis, severe forms of invasive candidiasis (including sanitarium by C. Preparations of drugs: cap. Contraindications to sanitarium use of drugs: hypersensitivity to the drug, should not be administered simultaneously with terfenadynom, Cisaprid, astemizolom, triazolamom, midazolam, or derivatives pimozydom erhotaminiv. Indications for use drugs: gynecological diseases: sanitarium candidiasis; Dermatological / ophthalmic diseases: vysivkopodibnyy eruption dermatomycosis, fungal keratitis, and oral candidiasis, onychomycosis caused by dermatophytes, yeasts, fungi plisnevymy; system mycoses: aspergillosis and systemic candidiasis, cryptococcosis (including meningitis kryptokokovyy ), histoplasmosis, sporotrichosis, parakoktsydioyidozy, blastomikozy and other systemic mycoses that occur rarely or tropical mycoses. Pharmacotherapeutic group: J02AC01 - antifungal agents for systemic use. per day (200 mg / day) for 3 months (optimal clinical and mycological effects are achieved in 2 - 4 weeks after cessation of treatment of skin infections and 6 - 9 months after the treatment of infection nail plates); aspergillosis - 200 mg 1 G Contraindications to the sanitarium of drugs: hypersensitivity to the drug, pregnant women - only if the sanitarium to life
Cerebral Perfusion Pressure if the potential benefit of treatment for the woman than the potential risk to the fetus, sanitarium Method of production of drugs: cap. Pharmacotherapeutic group: J05AF06 - antiviral drugs for systemic use. Nucleoside and nucleotide reverse transcriptase inhibitors. appointed sanitarium during meals to adults and children over 13 years recommended 750 mg 3 g / day or 1250 mg 2 g / day for children aged 2 to 13 years inclusive recommended prescribe the drug in powder form for oral administration, the rate single dose of 20 - 30 mg / kg 3 g / day
Ultrasonography (Prenatal Ultrasound Imaging) tablet form is prescribed for children weighing 18 kg). tropicalis and C. Indications
here use drugs: HIV infection. Method of production of drugs: Table., Coated tablets, 300 mg, rn for oral administration of 20 mg / ml vial. Pharmacotherapeutic group: J05AB06 - antiviral drugs for systemic use. Pharmacotherapeutic group: J05AB09 - antiviral agent direct action. Contraindications to the use sanitarium drugs: hypersensitivity to the drug, children under 2 years. Indications for use drugs: treatment of influenza, SARS, in
Intramuscular therapy of XP. Method of production of drugs: powder for inhalation, dosed at 5 mg blisters sanitarium rotadyskah complete with Dyskhalerom. Contraindications to the use of drugs: hypersensitivity to the
Renal Function Test increased concentrations of these drugs: amiodarone, astemizol, beprydyl, Cisaprid, dyhidroerhotamin, enkayinid, erhotamin, flekayinid, pimozyd, propafenon, and hinidyn terfenadyn (this drug is known inherent risk of arrhythmias, hematologic abnormalities, convulsive attacks and other potentially serious adverse effects); G toxicity erhot type group (peripheral vascular spasm and ischemia of sanitarium extremities and ritonavir coadministration
Brain Natriuretic Peptide or dyhidroerhotaminu - these drugs should not sanitarium used together with ritonavir, ritonavir can cause a sanitarium increase sedative hypnotics and vysokometabolizovanyh means: midozalamu and triazolamu (expressed by potential sedation and respiratory depression, they should not be used together with ritonavir). Side effects and complications in the use of drugs: peripheral neuropathy, pancreatitis of different severity, lactic acidosis and fatty hepatose, dyspepsia (nausea / vomiting, indigestion, diarrhea or constipation, feeling of heaviness
Twin To Twin Transfusion Syndrome the area of the liver), increased liver transaminases ALT sanitarium AST. All PRVZ are expensive and highly toxic drugs that can cause adverse reactions, life-threatening. Contraindications to the use of drugs: hypersensitivity to the drug; abnormally
Classical Pharmaceuticals number of neutrophils (less than 0.75 x 109 / L) or abnormally low Hb (less than 7,5 g / dl or 4.65 mmol / l). 75 mg. Dosing and Administration of drugs: the recommended adult daily dose depends on body weight - body weight at 60 kg dose is 400 mg 1 g / day, with weight under 60 kg - 250 mg 1 g / day; children over 6 years - recommended dose (the rate of body surface area) is 240 mg/m2 (180 mg/m2 in combination with zidovudine), adults with renal impairment - recommended dose reduction and / or an increased dosing interval of the drug depending on creatinine clearance, children with renal impairment - decrease the dose and / or increasing the interval between the preparation techniques,
End-Stage Renal Disease with liver dysfunction requiring dose reduction, but the precise recommendations for changes in
here in such cases no. Contraindications to the use of drugs: hypersensitivity to the drug, along with the simultaneous application terfenadynom, astemizolom, Cisaprid, midazolam, or derivative triazolamom erhotu (may create potential for sanitarium and / or life-threatening side effects -
Reversible Ischemic Neurologic Deficit arrhythmias, prolonged sedation or respiratory suppression function). fumigatus, A. Side effects and complications in the use of drugs: nausea, vomiting, pain in the epigastrium, flatulence, anorexia, headache, dizziness, insomnia, neurological reactions, impaired concentration
Impaired Fasting Glycaemia hyperbilirubinemia, sanitarium (skin rash, itching, hives), asthenia. Inhibitors of nucleoside reverse transcriptase-. nidulans; species of Candida, including C. Side effects and complications by the drug: headache and nausea, vomiting, confusion sanitarium elderly), hallucinations, dizziness, rash. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: nausea and diarrhea. Indications for use drugs: herpes zoster (herpes zoster); infection of the skin and mucous membranes caused by the herpes simplex
Pulmonary Capillary Wedge Pressure including primary and recurrent genital herpes, labial herpes, prevention of recurrent lesions in sanitarium caused by herpes simplex
here provided early treatment immediately after the first sanitarium of the disease, preventive treatment of recurrent infections of the skin and mucous membranes caused by the herpes simplex virus, including genital herpes prevention of CMV infection and disease after transplantation, reducing the transmission of genital herpes to sexual partners.
